We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together. 
days to go: Expired investment: £700,000
Ready Burger (RB) states that it has created the UK's first scalable, value-driven, entirely plant-based Quick Service Restaurant (QSR) brand. RB claims that it has mastered the science behind the taste and texture of plant-based foods to make them indistinguishable from their non-veg counterparts. It further points out that its final products use up to 92% lesser greenhouse gases, and require up to 70% lesser water than competitor brands. RB argues that its meals cater for vegetarians, vegans, meat lovers, and people preferring Halal or Kosher foods. RB offers fast-food classics and has partnered with a global plant-based food manufacturer. RB asserts that its ergonomically designed kitchens enable it to produce 1000s of items a day, that are in turn, serviced from its central distribution centre. RB's integrated web-app ordering, in-store ordering kiosks and an innovative delivery solution allow customers to have their food in under 30 minutes. RB says it will use the investment to grow its business across different verticals.
days to go: Expired investment: £1,998,549
This award-winning French wine company are seeking funding to further expand their business. Enhancing their barrel cellar is one of their main priorities, as well as planting new vines to increase quality and replacing low yield rows of vines entirely. With the investments made, they are also planning to export to new markets.
days to go: Expired investment: £145,972
Houseology are an online interior design company that allows the user to browse all aspects of design, ranging from designer furniture to lighting in a click-to-shop style.
days to go: Expired investment: £1,009,791
Go Banana are revolutionising the way tradesmen shop online for building supplies. They offer a free search tool for builders and DIY'ers to scan the market, compare prices and find supplies at the best possible price.     
days to go: Expired investment: £92,453
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph